Rezolute is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nevan Charles Elam, with a market cap of $338.8M.
Common questions about Rezolute
Rezolute is scheduled to report earnings for Q3 2026 on May 12, 2026 after market close.
Rezolute has approximately 51 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.